Next Article in Journal
The Pharmacokinetics and Pharmacodynamics of Iron Preparations
Next Article in Special Issue
Nano Delivers Big: Designing Molecular Missiles for Cancer Therapeutics
Previous Article in Journal
The Influence of Milling on the Dissolution Performance of Simvastatin
Pharmaceutics 2011, 3(1), 1-11; doi:10.3390/pharmaceutics3010001
Article

Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats

, , , , , *  and
Received: 24 November 2010; in revised form: 15 December 2010 / Accepted: 24 December 2010 / Published: 27 December 2010
(This article belongs to the Special Issue Nanotechnology in Drug Delivery)
View Full-Text   |   Download PDF [173 KB, uploaded 27 December 2010]   |   Browse Figures
Abstract: We have reported that PEGylated liposomes lose their long-circulating properties when they are administered repeatedly at certain intervals to the same animal. This unexpected phenomenon is referred to as the accelerated blood clearance (ABC) phenomenon. We recently showed that the ABC phenomenon is triggered via the abundant secretion of anti-PEG IgM in response to the first dose of PEGylated liposomes. However, the details of the underlying mechanism for the induction of anti-PEG IgM production are yet to be elucidated. The present study demonstrated that the spleen is a major organ involved in the secretion of anti-PEG IgM in mice and rats. Anti-PEG IgM production was detected in nude, T-cell deficient mice, but not in SCID mice with B- and T-cell deficiencies. These observations indicate that splenic B-cells secret anti-PEG IgM without help from T-cells. Sequential injections of PEGylated liposomes into the same mice did not promote isotype switching from IgM to IgG. Accordingly, PEGylated liposomes may function as a type-2, T-cell-independent antigen (TI-2 antigen) during anti-PEG IgM production. Although the underlying mechanism that causes an anti-PEG IgM response against PEGylated liposomes is not yet clear, our findings give implications in revealing the anti-PEG IgM response against PEGylated liposome.
Keywords: Polyethyleneglycol (PEG); PEGylated liposome; Anti-PEG IgM; Accelerated blood clearance (ABC) phenomenon; spleen Polyethyleneglycol (PEG); PEGylated liposome; Anti-PEG IgM; Accelerated blood clearance (ABC) phenomenon; spleen
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Ichihara, M.; Shimizu, T.; Imoto, A.; Hashiguchi, Y.; Uehara, Y.; Ishida, T.; Kiwada, H. Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats. Pharmaceutics 2011, 3, 1-11.

AMA Style

Ichihara M, Shimizu T, Imoto A, Hashiguchi Y, Uehara Y, Ishida T, Kiwada H. Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats. Pharmaceutics. 2011; 3(1):1-11.

Chicago/Turabian Style

Ichihara, Masako; Shimizu, Taro; Imoto, Ami; Hashiguchi, Yuki; Uehara, Yumi; Ishida, Tatsuhiro; Kiwada, Hiroshi. 2011. "Anti-PEG IgM Response against PEGylated Liposomes in Mice and Rats." Pharmaceutics 3, no. 1: 1-11.


Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert